Skip to content
10-Q

Quarterly Report

NUTEX HEALTH INC. NUTX

0001628280-26-028849

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 28, 2026 6.88M sh
Shares Diluted Q1 2026 · Mar 31, 2026 7.18M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $31.73M
Stock Repurchased Q1 2026 · Mar 31, 2025 $0
Capex Q1 2026 · Mar 31, 2026 $1.2M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $75.52M
Long Term Debt Q1 2026 · Mar 31, 2026 $24.26M
Long Term Debt Q1 2026 · Dec 31, 2025 $29.17M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $207.35M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $185.57M
Stockholders Equity Q1 2026 · Mar 31, 2026 $346.29M
Stockholders Equity Q1 2026 · Dec 31, 2025 $329.45M
Current Liabilities Q1 2026 · Mar 31, 2026 $184.44M
Current Liabilities Q1 2026 · Dec 31, 2025 $157.91M
Total Liabilities Q1 2026 · Mar 31, 2026 $515.27M
Total Liabilities Q1 2026 · Dec 31, 2025 $495.09M
Current Assets Q1 2026 · Mar 31, 2026 $579.65M
Current Assets Q1 2026 · Dec 31, 2025 $538.81M
Total Assets Q1 2026 · Mar 31, 2026 $957.32M
Total Assets Q1 2026 · Dec 31, 2025 $918.53M
Eps Diluted Q1 2026 · Mar 31, 2026 $6.52
Eps Basic Q1 2026 · Mar 31, 2026 $6.70
Sga Expense Q1 2026 · Mar 31, 2026 $14.38M
Net Income Q1 2026 · Mar 31, 2026 $46.81M
Operating Income Q1 2026 · Mar 31, 2026 $81.27M
Gross Profit Q1 2026 · Mar 31, 2026 $91.73M